- Available history
- No dated observations
- Data captured
IPO Date coverage
MAZE IPO Date summary
Maze Therapeutics, Inc. (MAZE). What the retained company guidance contains and how many periods can be scored.
| Measure | Value |
|---|---|
| Legal name | Maze Therapeutics, Inc. |
| Ticker | MAZE |
| Exchange | Nasdaq |
| IPO date | 31 Jan 2025 |
| Country | United States |
| Final IPO prospectus | Form 424B4 filed 2025-01-31, accession 0001193125-25-018482 |
| Registration statement | Form S-1 filed 2025-01-07, accession 0001193125-25-002851 |